170 related articles for article (PubMed ID: 26454338)
1. The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin.
Wang L; Yan J; Li Y; Xu K; Li S; Tang P; Li H
J Pharm Biomed Anal; 2016 Jan; 117():453-63. PubMed ID: 26454338
[TBL] [Abstract][Full Text] [Related]
2. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
Wang L; Li S; Tang P; Yan J; Xu K; Li H
Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxypropyl-β-cyclodextrin on the bounding of salazosulfapyridine to human serum albumin.
Tang P; Tang B; Wang Q; Xu K; Xiong X; Li H
Int J Biol Macromol; 2016 Nov; 92():105-115. PubMed ID: 27418290
[TBL] [Abstract][Full Text] [Related]
4. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
5. Spectral and molecular modeling studies on the influence of β-cyclodextrin and its derivatives on aripiprazole-human serum albumin binding.
Yan J; Wu D; Ma X; Wang L; Xu K; Li H
Carbohydr Polym; 2015 Oct; 131():65-74. PubMed ID: 26256161
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
Tang P; Li S; Wang L; Yang H; Yan J; Li H
Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.
Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L
Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819
[TBL] [Abstract][Full Text] [Related]
9. Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
Tang P; Ma X; Wu D; Li S; Xu K; Tang B; Li H
Carbohydr Polym; 2016 May; 142():16-23. PubMed ID: 26917368
[TBL] [Abstract][Full Text] [Related]
10. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
Liu B; Li W; Nguyen TA; Zhao J
Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
[TBL] [Abstract][Full Text] [Related]
11. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
12. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex.
Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM
Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411
[TBL] [Abstract][Full Text] [Related]
13. Host-guest inclusion system of scutellarein with 2-hydroxypropyl-beta-cyclodextrin: preparation, characterization, and anticancer activity.
Wang F; Yang B; Zhao Y; Liao X; Gao C; Jiang R; Han B; Yang J; Liu M; Zhou R
J Biomater Sci Polym Ed; 2014; 25(6):594-607. PubMed ID: 24555409
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
Liu M; Cao W; Sun Y; He Z
Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclodextrins on protein binding of drugs: the diflunisal/hydroxypropyl-beta-cyclodextrin model case.
Sideris EE; Koupparis MA; Macheras PE
Pharm Res; 1994 Jan; 11(1):90-5. PubMed ID: 8140060
[TBL] [Abstract][Full Text] [Related]
17. Solubility and dissolution rate improvement of the inclusion complex of apigenin with 2-hydroxypropyl-β-cyclodextrin prepared using the liquid antisolvent precipitation and solvent removal combination methods.
Wu W; Zu Y; Zhao X; Zhang X; Wang L; Li Y; Wang L; Zhang Y; Lian B
Drug Dev Ind Pharm; 2017 Aug; 43(8):1366-1377. PubMed ID: 28402147
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Wang S; Ding Y; Yao Y
Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex.
Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G
Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865
[TBL] [Abstract][Full Text] [Related]
20. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
Garnero C; Zoppi A; Genovese D; Longhi M
Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
